C12N 2740/11044
Chimeric viral vector comprising heterologous viral elements for production of another viral
Official title: Chimeric viral vector comprising heterologous viral elements for production of another viral vector
C12N2740/11044 (Chimeric viral vector comprising heterologous viral elements for production of another viral) appears on 6 US grants and 3 published applications in this corpus.
Search patents in C12N- Granted patents
- 6
- Published applications
- 3
- Assignees
- 3
- Inventors
- 4
- Latest grant
- 30 Sep 2014
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Method and means for producing high titer, safe recombinant lentivirus vectors30 Sep 2014US 8,846,385 B2Gbp IP, LLC
- Method and means for producing high titer, safe, recombinant lentivirus vectors1 Aug 2006US 7,083,981 B2Cell Genesys, Inc.
- Method and means for producing high titer, safe, recombinant lentivirus vectors2 Aug 2005US 6,924,144 B2Cell Genesys, Inc.
- Method and means for producing high titer, safe, recombinant lentivirus vectors6 Aug 2002US 6,428,953 B1Cell Genesys, Inc.
- Method and means for producing high titer, safe, recombinant lentivirus vectors26 Dec 2000US 6,165,782 ACell Genesys, Inc.
- Method and means for producing high titer, safe recombinant lentivirus vectors20 Nov 2008US 2008/0286836 A1Cell Genesys, Inc.
- Method and means for producing high titer, safe, recombinant lentivirus vectors17 Nov 2005US 2005/0255597 A1Cell Genesys, Inc.
- Method and means for producing high titer, safe, recombinant lentivirus vectors21 Nov 2002US 2002/0173030 A1Cell Genesys, Inc.
Most cited
By later US patents
- Method and means for producing high titer, safe, recombinant lentivirus vectors261US 5,994,136 ACell Genesys, Inc. · 1999
- Method and means for producing high titer, safe, recombinant lentivirus vectors89US 6,165,782 ACell Genesys, Inc. · 2000
- Method and means for producing high titer, safe, recombinant lentivirus vectors64US 6,428,953 B1Cell Genesys, Inc. · 2002
- Method and means for producing high titer, safe, recombinant lentivirus vectors9US 7,083,981 B2Cell Genesys, Inc. · 2006
- Method and means for producing high titer, safe, recombinant lentivirus vectors4US 6,924,144 B2Cell Genesys, Inc. · 2005